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Abstract: Bacillus thuringiensis (Bt) produces insecticidal proteins that are either secreted during the
vegetative growth phase or accumulated in the crystal inclusions (Cry proteins) in the stationary
phase. Cry1I proteins share the three domain (3D) structure typical of crystal proteins but are secreted
to the media early in the stationary growth phase. In the generally accepted mode of action of 3D
Cry proteins (sequential binding model), the formation of an oligomer (tetramer) has been described
as a major step, necessary for pore formation and subsequent toxicity. To know if this could be
extended to Cry1I proteins, the formation of Cry1Ia oligomers was studied by Western blot, after the
incubation of trypsin activated Cry1Ia with insect brush border membrane vesicles (BBMV) or insect
cultured cells, using Cry1Ab as control. Our results showed that Cry1Ia oligomers were observed only
after incubation with susceptible coleopteran BBMV, but not following incubation with susceptible
lepidopteran BBMV or non-susceptible Sf21 insect cells, while Cry1Ab oligomers were persistently
detected after incubation with all insect tissues tested, regardless of its host susceptibility. The data
suggested oligomerization may not necessarily be a requirement for the toxicity of Cry1I proteins.
Keywords: Cry1Ab; oligomer formation; Sf21 cell line; Ostrinia nubilalis; Lobesia botrana; Leptinotarsa
decemlineata; bioassay
Key Contribution: The paper studies the oligomer formation of trypsin activated Cry1I in vitro,
after incubation with insect BBMV or insect cultured cells. The results show that Cry1Ia oligomers
are only visualized after incubation with coleopteran susceptible BBMV. This could suggest that
oligomerization may not be a limiting step in the mode of action of Cry1I protein.
1. Introduction
The entomopathogenic Gram-positive bacterium, Bacillus thuringiensis (Bt), is the most successful
bioinsecticide commercialized to date. It generates a wide variety of insecticidal proteins that can
be produced at different growth stages. Cry, Cyt and parasporin proteins are synthetized during
the stationary growth phase, Cry1I proteins are secreted in the initial phase of sporulation and Vip
and Sip proteins are secreted during the vegetative phase of bacterial growth [1–5]. The success of
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Bt-based insecticides is due to its narrow spectrum of activity, environmental safety and because it is
harmless to animals and plants [6]. To date, the most studied Bt entomopathogenic proteins are the
three domain (3D) Cry proteins such as Cry1 and Cry2 toxins. Their mode of action is not completely
known, but it is commonly accepted that specific binding to insect midgut receptors is essential to exert
their toxicity [7,8]. The current models of Cry toxin action include the “signal transduction model”
that claims that the toxicity is mediated by intracellular pathways [9], and the “sequential mode of
action”—the most accepted model so far, that is based on the sequential binding of Bt toxin to several
midgut receptors, the promotion of a pre-pore oligomer, the insertion of pre-pore oligomer into the
midgut membrane, pore formation, osmotic imbalance, midgut epithelium disruption, septicemia and
insect death [10]. Regarding this model, some authors have stated that the formation of the oligomer
prior to toxin insertion into membrane is a major step in the toxicity process, and that the oligomeric
(tetrameric) structure, is necessary for the final pore formation; also, it has been claimed that the
oligomer formation is a conserved mechanism in the mode of action of the Cry proteins [11–16].
Oligomerization has been studied in several wild type and mutant toxins such as Cry1Aa, Cry1Ab,
Cry1Ac, Cry1Ca, Cry1Da, Cry1Ea, Cry1Fa, Cry2Ab, Cry3Aa, Cry3Ba, Cry3Ca, Cry4Ba, Cry11Aa and
Cry46Aa1 [15,17–25]. Oligomerization has also been detected in other Bt toxins such as Cyt [26] and
Vip [27]. However, regarding the Cry1I protein family, only one study has described the possible
oligomerization of this protein in solution, in the absence of insect midgut proteins [28]. So far,
the promotion of Cry1I oligomer formation after incubation with insect tissues or insect cell-derived
models has never been experimentally addressed.
Cry1I proteins are included within the Cry1 family (3D Cry proteins) because of their sequence
similarities and structural characteristics. However, Cry1I proteins display several unique, specific
and remarkable characteristics, that include their secretion early in the stationary growth phase of Bt
(instead of forming part of the Bt crystals), their unusual protoxin molecular weight (80 kDa), and the
dual insecticidal activity against lepidopteran and coleopteran pests [29,30]. This, together with the
lack of cross-resistance with other Cry1A and Cry1F insecticidal proteins [31–33], make Cry1I proteins
interesting for developing new insecticidal products and indeed, they have been recently introduced
in Bt crops [34,35].
Understanding the mode of action of Bt toxins is critical for enhancing and sustaining their
efficacy against pests. In this context, in the present work, for the first time, the oligomer formation
of Cry1Ia toxins has been examined after incubation with midgut insect tissues, trying to clarify
its relevance in the Cry1I mode of action. Cry1Ab, for which oligomerization has been reported
in several studies [36–39], has been used as control. In this study, midgut brush border membrane
vesicles (BBMV) of different insect species from Lepidoptera (Ostrinia nubilalis and Lobesia botrana) and
Coleoptera (Leptinotarsa decemlineata), as well as a cell line derived from Spodoptera frugiperda (Sf21)
were used to promote the Cry oligomer formation. This selection covered both susceptible and tolerant
insect species for Cry1Ia and Cry1Ab. Based on this, the oligomer formation of Cry1Ia toxin compared
to Cry1Ab, and its possible correlation with insecticidal activity, have been examined.
2. Results
2.1. Toxicity of Cry1Ia and Cry1Ab against Lepidopteran and Coleopteran Species
The toxicity of Cry1Ia and Cry1Ab protoxins towards the insects’ species used in the present study
were assessed by performing bioassays. The results are summarized in Table 1. The Cry1Ia protein was
found to be toxic for the two selected lepidopteran species, L. botrana, and O. nubilalis, with LC50 values
of 80 and 273 ng/cm2 respectively, as well as for the coleopteran L. decemlineata (LC50 = 22 µg/mL).
On the other hand, Cry1Ab was only toxic for the lepidopteran insect species.
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Table 1. Toxicity parameters of Cry1Ab and Cry1Ia protoxins.
Insect Species Bt Toxins LC50
Fiducial Limits (95%) Regression Line
Lower Upper Slope ± SE a ± SE
L. botrana
Cry1Ab 153 106 217 1.15 ± 0.13 2.48 ± 0.3
Cry1Ia 80 56 108 1.28 ± 0.13 2.56 ± 0.31
O. nubilalis
Cry1Ab 69 47 97 1.06 ± 0.11 3.04 ± 0.23
Cry1Ia 273 88 1011 1.50 ± 0.15 1.34 ± 0.14
L. decemlineata
Cry1Ab NT - - - -
Cry1Ia 22 12 53 0.51 ± 0.07 4.29 ± 0.09
LC50 values are expressed as ng/cm2 for L. botrana and O. nubilalis, and in µg/mL for L. decemlineata. NT: non-toxic at
100 µg/mL.
2.2. BBMV of Susceptible Lepidopteran Insects Promoted Oligomerization of Cry1Ab But Not of Cry1Ia
The oligomer formation of Cry1Ab and Cry1Ia was studied by incubating the proteins with
lepidopteran BBMV from O. nubilalis and L. botrana, susceptible hosts (Table 1). In order to favor
oligomer detection, the milder SDS-PAGE denaturing conditions used in the bibliography to observe
Cry1 oligomers were employed (see Section 4.8 in Materials and Methods). The results showed that
Cry1Ab toxin was able to form oligomers after incubation with BBMV from O. nubilalis, but this
incubation did not promote Cry1Ia oligomer formation (Figure 1). The oligomers observed (band of
about 250 kDa) were associated to the O. nubilalis BBMV fraction (Figure 1a, lane P); these oligomeric
structures could be inserted into the membranes or just bound to the surface of the BBMV due to
interaction with specific membrane proteins. For Cry1Ab, the Western blot revealed another band
with a molecular weight of approximately 60 kDa, corresponding to the monomeric form of Cry1Ab
(Figure 1a, lane P). Nevertheless, the Cry1Ia protein associated with O. nubilalis BBMV was detected as
a single band of about 50 kDa, corresponding to Cry1Ia monomers, and no band corresponding to
Cry1Ia oligomers was detected (Figure 1b, lane P). The Cry1Ab and Cry1Ia monomeric proteins were
also recovered in the supernatants, as bands of about 60 and 50 kDa, respectively (Figure 1, lanes S).
Controls of Cry1Ab or Cry1Ia proteins without BBMV, but subjected to the same process as the rest of
the samples, were conducted to assess the possible spontaneous formation of oligomers. The results
(Figure 1, lanes C) showed the presence of Cry1Ab and Cry1Ia monomers mostly while the oligomers
(tetramers) were not detected in these lanes, pointing to the fact that Cry1Ab and Cry1Ia tetramers
did not form spontaneously in the solution in the absence of insect BBMV. In the case of Cry1Ia some
minor bands of MW about 65 and 90 kDa were detected, which were most probably traces of Cry1Ia
protoxin and partially trypsinized products; a third minor band of about 130 kDa (MW that does not
match with the size of Cry1Ia dimers or trimers) was also observed.
The oligomer formation was also tested using BBMV from L. botrana. The results obtained were
similar to the ones found with O. nubilalis BBMV. The incubation of Cry1Ia with BBMV from L. botrana,
did not render bands with molecular weight consistent with Cry1Ia oligomeric structures (Figure 2b,
lane P), whilst, after incubation of Cry1Ab with L. botrana BBMV, a clear band corresponding to a
Cry1Ab oligomer (tetramer) was observed (Figure 2, lane P). On the other hand, monomers of both
proteins were detected in the corresponding supernatants recovered after the BBMV-protein incubation
assays (Figure 2, lanes S). In the Cry1Ia experiments, minor bands of MW of about 65 and 90 kDa
were observed in the supernatant (S) and control (C) lanes that probably represent a minor fraction of
partially trypsinized Cry1Ia.
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Figure 1. Cry1Ab and Cry1Ia oligomer formation promoted by O. nubilalis BBMV: (a) Cry1Ab;
(b) Cry1Ia. Lanes B: O. nubilalis BBMV incubated without Cry1Ab or Cry1Ia proteins. Lanes C: Control
of Cry1Ab or Cry1Ia proteins, incubated without BBMV. Lanes S: Supernatant obtained after incubation
of Cry1Ab or Cry1Ia proteins, with the BBMV. Lanes P: Pellet obtained after incubation of Cry1Ab
or Cry1Ia with the BBMV. Lanes M: Molecular weight marker. The arrowhead points to the Cry1Ab
oligomer (about 250 kDa).
Figure 2. Cry1Ab and Cry1Ia oligomer formation promoted by L. botrana BBMV: (a) Cry1Ab; (b) Cry1Ia.
Lanes B: L. botrana BBMV incubated without Cry1Ab or Cry1Ia proteins. Lanes C: Controls of Cry1Ab
or Cry1Ia proteins incubated without BBMV. Lanes P: Pellet obtained after incubation of the respective
protein with the L. botrana BBMV. Lanes S: Supernatant obtained after incubation of the respective
protein with the L. botrana BBMV. Lanes M: molecular weight marker. The arrowhead points to the
Cry1Ab oligomer (about 250 kDa).
2.3. Oligomerization of Cry1Ia Was Promoted by BBMV from L. decemlineata
Cry1Ia exhibits a dual toxic activity towards lepidopteran and coleopteran hosts, whereas Cry1Ab
is only toxic to lepidopteran species. In this work, L. decemlineata BBMV was employed as a coleopteran
Cry1Ia susceptible host tissue (Table 1) to study Cry1Ia oligomer promotion as well to study if these
BBMV promoted the oligomerization of the Cry1Ab protein, non-toxic for this insect species (Table 1).
The results, summarized in Figure 3, showed that the incubation of either Cry1Ab or Cry1Ia toxins
with the coleopteran BBMV provided bands of a molecular weight of about 250 kDa for both Cry
proteins, corresponding to the respective oligomers. Interestingly, the oligomers were detected in both,
pelleted (BBMV) and supernatant fractions (Figure 3, lanes P and S respectively). Bands corresponding
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to the monomers of both proteins were also observed in both fractions (pelleted BBMV and supernatant)
for both Cry proteins. Incubation with Cry1Ab rendered also a band of about 150 kDa that could
correspond to a dimer. It is worth highlighting that the band corresponding to the Cry1Ia oligomer had
a molecular weight of about 250 kDa, which would indicate that Cry1Ia oligomer could be composed
by more than four subunits, since the Cry1Ia monomer has a size of about 50 kDa. Moreover, a strong
band of molecular weight higher than 250 kDa was also observed as being associated to the BBMV
(Figure 3, lane P) that could correspond to Cry1Ia aggregates with high number of units.
Figure 3. Cry1Ab and Cry1Ia oligomer formation promoted by L. decemlineata BBMV: (a) Cry1Ab;
(b) Cry1Ia. Lanes B: L. decemlineata BBMV incubated without Cry1Ab or Cry1Ia proteins. Lanes
C: Controls of Cry1Ab or Cry1Ia proteins incubated without BBMV. Lanes P: Pellet obtained after
incubation of the respective protein with the L. decemlineata BBMV. Lanes S: Supernatant obtained after
incubation of the respective protein with the L. decemlineata BBMV. Lanes M: molecular weight marker.
The arrowheads in panels (a,b) point to the Cry1Ab (about 250 kDa) and the Cry1Ia (about 250 kDa)
oligomer bands respectively.
2.4. Oligomerization Promoted by Sf21 Insect Cells
It has been described that Sf21 cells (insect cultured cells derived from S. frugiperda ovaries) are
tolerant to both Cry1Ab and Cry1Ia proteins [40,41]. These insect cells were selected in order to check
if oligomer formation could be promoted by tolerant insect tissues. Figure 4 shows the results of
the incubation of Sf21 cells with each one of these proteins. In the case of Cry1Ab, the incubation
of the protein with the insect cells resulted in the detection of two main bands of approximately 60
and 250 kDa associated with the cell fraction, corresponding to Cry1Ab monomers and oligomers,
respectively (Figure 4a, lane P). Other minor bands detected were also present in the control lanes of
Sf21 cells that had been incubated without Cry proteins, showing that these bands probably correspond
to natural biotinylated proteins present in the cells (Figure 4, lanes B). In the case of Sf21 cells incubated
with Cry1Ia, only a band with the molecular weight of the monomer (50 kDa) was found to be
associated with the cells (Figure 4b, lane P). In summary, results pointed out the absence of Cry1Ia
oligomer formation after incubation with Sf21 cells, in contrast to what is observed after incubation
with Cry1Ab. It is worth noting that in the supernatants, only a main band with the molecular weight
of the Cry1Ab or Cry1Ia monomers, was detected (Figure 4, lanes S).
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Figure 4. Cry1Ab and Cry1Ia oligomer formation promoted by Sf21 cells: (a) Cry1Ab; (b) Cry1Ia.
Lanes B: Sf21 cells incubated without Cry1Ab or Cry1Ia proteins. Lanes C: Controls of Cry1Ab or
Cry1Ia proteins incubated without Sf21 cells. Lanes P: Pellet obtained after incubation of the respective
protein with the Sf21 cells. Lanes S: Supernatant obtained after incubation of the respective protein
with the Sf21cells. Lanes M: molecular weight marker. The arrowhead in Cry1Ab panel points to the
Cry1Ab oligomer.
3. Discussion
Cry1I proteins share sequence and structural similarities to the most-known three domain Cry
proteins present in the parasporal crystal of Bt [10,29,42]. Therefore, so far, it has been assumed that
their mode of action is similar to its crystal protein counterparts, despite their special features such as
that the Cry1I proteins do not form crystals [5,43], their protoxin MW is smaller (about 81 kDa [29]),
and they show dual toxic activity against lepidopteran and coleopteran insect pests [29,44].
The mode of action of the Cry proteins accumulated in the crystals is not completely
understood [10,12]. It is commonly accepted that includes the solubilization of the crystals in
the insect midgut to yield the protoxin form, and a proteolytic processing to produce the activated
forms. Then, the “sequential binding model”, suggests that the activated proteins bind to several
midgut membrane receptors to finally form an oligomeric structure that inserts in the midgut membrane
and forms pores, leading to cellular osmotic imbalance, cell lysis, septicaemia and eventually insect
death [13,14]. In support of this model, several studies have reported that oligomerization plays a
crucial role in the insecticidal activity of B. thuringiensis Cry toxins [18,38,45,46]. Moreover, Cry protein
mutants that did not form oligomers, showed severely decreased toxicity [17,24,45]. Likewise, it
has been shown that some Cry1A mutants that had lost their toxicity, were unable to oligomerize
and to form pores [38,47]. However, despite these studies, the sequential binding to several insect
membrane proteins as well as the oligomer formation and insertion events prior to pore formation are
not clearly defined yet [12]. On the other hand, as an alternative to the “sequential binding model”,
the “signaling pathway model” has been proposed. This model claims that the Cry toxicity can be
due to the activation of intracellular cell death pathways [9]. Indeed, some authors claim that both
mechanisms could coexist [48].
In this context, the occurrence of an oligomerization step in the mode of action of Cry1Ia protein,
and the study of Cry1Ia oligomerization promotion by membranes of susceptible and tolerant insect
BBMV or insect cells, have been the main goals of this research.
In 2009, the occurrence of a spontaneous oligomerization of trypsinized Cry1Ie in solution was
reported [28]. According to the mentioned research, the oligomer fraction contained a small amount
of dimer and a large amount of aggregates larger than tetramers. The toxicity of the oligomers
against Plutella xylostella was about 70 times lower than the toxicity of the monomer or the toxicity
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of the non-trypsinized Cry1Ie protein, which led the authors to claim that the Cry1Ie spontaneous
aggregation most likely differ from the oligomers occur by the insect midgut membranes. In the present
work, the oligomerization of Cry1Ia protein after incubation with susceptible insect BBMV or with
non-susceptible cultured insect cells, has been determined for the first time.
To properly select the insect species for this study, the insecticidal activity of Cry1Ia and Cry1Ab
protoxins towards two lepidopteran species (O. nubilalis and L. botrana) and a coleopteran insect (L.
decemlineta) has been assessed. The toxicity data obtained were expected based on the published
data [29,44,49,50]. Moreover, Sf21 cells were also used in this study, on the bases that Cry1Ia and
Cry1Ab are not toxic for them [40,41].
So far, Cry oligomerization studies have focused on the incubation of the Cry proteins with
BBMV of susceptible and resistant populations of the same insect, and, as a result, an association has
been found between resistance and reduced oligomerization [51,52]. In the present work, we have
used Cry1Ab as an oligomeric control protein [36–39], and have been able to clearly detect Cry1Ab
oligomers in the expected tetramer form (about 250 kDa molecular weight size) after incubation with
all tested insect tissues, regardless to their susceptibility. Thus, oligomers have been observed after
incubation of the trypsinized Cry1Ab protein with O. nubilalis or L. botrana BBMV (susceptible insects),
but also with L. decemlineata BBMV (non-susceptible insect) and Sf21 cells (non-susceptible cultured
insect cells). The oligomeric structures were found associated to the insect BBMV or to the insect cells,
indicating that they were either inserted or bound to the membrane proteins. The finding of Cry1Ab
oligomers after incubation with tolerant insect BBMV or associated with tolerant insect cells could be
explained by an improper insertion of oligomers into the membranes (and therefore inefficiency to
produce damages), or by the inability to induce the post-pore subsequent events in the cells (e.g., no
triggering of cell death mechanisms).
In this study, the Cry1Ab oligomer was mainly found to be associated to the membrane fractions
in accordance with previous reports, but oligomers were also observed in the supernatants after
incubation with BBMV from the non-susceptible insect L. decemlineata. This suggested that the Cry1Ab
oligomers (tetramers and dimers), promoted by the coleopteran BBMV, are not only associated to
the BBMV (whether inserted or not) but also free in the supernatant (Figure 3a, lane S). The results
obtained resemble the ones shown by Rodríguez-Almazán et al. [47], with the Cry1Ab helixα-4 mutants
which had a mutation in domain I, involved in membrane insertion and pore formation, and had lost
drastically their insecticidal activity towards M. sexta larvae. Similarly, in our results, the incubation of
Cry1Ab with BBMV from L. decemlineata rendered a relatively high amount of oligomeric structures
(dimers and tetramers) in the supernatant, apparently indicating that these oligomers were not able to
insert into the membranes, resulting in the absence of toxicity. Nevertheless, in this study, after the
incubation of the Cry1Ia protein with L. decemlineata BBMV, a high proportion of Cry1Ia oligomers
were also observed in the supernatants (Figure 3b, laneS), and in this case, the protein showed a high
toxicity against this coleopteran pest (Table 1).
The Cry1Ia oligomers were observed after incubation of the protein with BBMV from the
susceptible coleopteran L. decemlineata. The molecular weights of the bands that correspond to the
Cry1Ia oligomers (about 250 kDa) point out that the Cry1Ia oligomer could be composed of more than
four units.
After incubation of Cry1Ia with BBMV of susceptible lepidopterans (O. nubilalis and L. botrana) or
with insect Sf21 cells, no oligomers were detected, suggesting that the Cry1Ia proteins associated to the
lepidopteran membranes could be mainly in monomeric forms. In this case, oligomers would not be
a limiting step in the toxicity of Cry1Ia proteins, and the toxicity could be mediated by intracellular
signaling pathways [9]. Moreover, other hypotheses could be mentioned to explain the reason for
the absence of Cry1Ia oligomers. Firstly, it can be suggested that the observed monomers come
from disassembled oligomers produced due to the SDS-PAGE technique conditions, similarly to
what was proposed by Ocelotl et al. [51] working with Cry1Ab oligomers. However, this reasoning
would be in conflict with the observation of oligomers after the incubation of Cry1I with coleopteran
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BBMV, which were detected using the same SDS-PAGE conditions. Secondly, it could be considered
that the biotinlylation of Cry1I could interfere with oligomerization. This hypothesis was examined
following the incubation of the biotin labelled Cry1Ab with O. nubilalis BBMV. The results showed
no influence of biotin in oligomerization (Figure S1), similarly to what had been already claimed
by other authors showing that biotinylation of Cry proteins does not prevent their oligomerization,
binding and insecticidal activity [12,53,54]. Thirdly, it has to be noticed that, in the present study,
the oligomer formation experiments were performed with trypsinized Cry1Ab and Cry1Ia proteins to
mimic the in vivo conditions. It has been described that Cry1Ie protoxin and trypsinized protein have
the same toxicity [28]. However, other Cry1I proteins such as Cry1Ia1 have shown some differences in
toxicity amongst protoxins (more active) and trypsinized proteins [49]. We can speculate that in vitro
trypsinization of Cry1Ia could alter the toxicity by impairing oligomer formation, maybe provoking a
flawed ability to form oligomers when they are promoted by lepidopteran BBMV.
The spontaneous formation of Cry1Ab and Cry1Ia oligomers in solution has been questioned in
this study. Cry1Ab submitted to the same experimental situation of treatments, but without being
in contact with insect BBMV or cells, did not oligomerize (Figures 1, 2, 3 and 4a, lanes C). Regarding
Cry1Ia, some bands of smaller sizes than the expected tetramer, and with MW sizes that were not
multiples of 50 kDa (monomer size) were observed (Figures 1, 2, 3 and 4b, lanes C). Most probably,
these bands are residual incomplete trypsinized Cry1Ia forms, dragged through the toxin purification
process. In conclusion, although some studies have reported the spontaneous formation of Cry protein
oligomers in solution without being in contact with the membrane-like environment (i.e., Cry4Ba [55]
or Cry2Ab [24]), in our study neither Cry1Ab nor Cry1Ia formed oligomers without being exposed to
insect BBMV or cultured insect cells.
In summary, our findings indicated that the oligomers of a classical 3D crystal forming Cry protein
of Bt such as Cry1Ab were promoted and could be detected after incubation of activated Cry1Ab with
susceptible or non-susceptible insect midgut BBMV and with non- susceptible Sf21 cells. In contrast,
in the same assay conditions, Cry1Ia oligomers were detected only after incubation with BBMV of L.
decemlineata (coleopteran susceptible host), but no Cry1Ia oligomeric structures were found following
incubation of Cry1Ia with lepidopteran BBMV or with the Sf21 cells, regardless of its host susceptibility.
Hence, our results, using trypsin processed Cry1Ab and Cry1Ia as an in vitro model of what might
occur in vivo, suggest that: (1) The promotion of oligomers can occur by incubation of the Cry toxin
with susceptible insect BBMV but also with non-susceptible insect tissues, and (2) The oligomerization
may not be a determining step in the toxicity of Cry1I proteins.
4. Materials and Methods
4.1. Production and Purification of Cry Proteins
The Cry1Ab protein used for oligomer formation was obtained from a recombinant Escherichia coli
strain GG094-208 (kindly supplied by Dr. R.A. de Maagd, Wageningen University, The Netherlands).
Protein expression, inclusion bodies purification, solubilization and protoxin activation by trypsin,
were performed as described previously [56]. The activated Cry1Ab was purified by anion-exchange
chromatography using Äkta 100 explorer system (GE Healthcare, Amersham, UK) following
Crava et al. [57]. The eluted fractions from the column were individually analysed by sodium
dodecyl sulphate-12% polyacrylamide gel electrophoresis (SDS-PAGE).
The cry1Ia7 gene was cloned and expressed in E. coli, BL21(DE3) cells [40]. The purification of the
protein by affinity chromatography using a HisTrapTM FF crude column (GE Healthcare Bio-Sciences,
Upsala, Sweden), protein dialysis and protoxin activation by trypsin, were performed as reported by
Khorramnejad et al. [40]. The activated Cry1Ab and Cry1Ia were visualized after SDS-PAGE, and their
concentration was estimated by densitometry using TotalLab Quant program version 12.3 (Newcastle,
UK), employing bovine serum albumin as standard.
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The Cry1Ab protein used in bioassays (protoxin) was obtained from a recombinant Bt strain
that produced a crystal composed solely of the Cry1Ab protein, kindly supplied by Dr. Colin Berry,
Cardiff University, Cardiff, UK. This Bt strain was grown in CCY medium [58] supplemented with
erythromycin and the crystal formation was observed daily. When at least 95% of the cells were lysed,
the fermentation process was stopped and then spores and crystals were collected by centrifugation
(8600× g, 4 ◦C), washed with a saline solution (NaCl 1M, EDTA 10mM) and resuspended in KCl
(10 mM). For Cry1Ia7 protoxin production, the recombinant E. coli BL21 (DE3) was grown and purified
as described above. Both Cry1Ab and Cry1Ia7 protoxins were quantified by the method of Bradford [59]
using BSA as standard, and kept at 4 ◦C until used.
4.2. Insect Rearing
Two different lepidopteran species, L. botrana (Lep: Tortricide) and O. nubilalis Hübner (Lep.:
Crambidae), and one coleopteran species, L. decemlineata (Col.: Chrysomelidae) (the Colorado potato
beetle, CPB) were used in this study. Both lepidopteran pests were maintained in the insectary
of the Universidad Pública de Navarra (UPNA, Pamplona, Spain) at 25 ◦C ± 1 ◦C with 70% ± 5%
RH and a photoperiod of 16/8 h (light/dark) on the artificial diet described by MacIntosh et al. [60].
The population of beetles was raised on potato plants (Desiré variety) grown throughout the year in a
phytotron to provide a continuous supply of food substrate. This population was refreshed 1–2 times
every year by the introduction of wild adults collected in the field during the spring-summer.
4.3. Insect Cell Line
The lepidopteran cell line Sf21, from ovaries of fall armyworm S. frugiperda (Lep.: Noctuidea), was
obtained from Wageningen University (Wageningen, The Netherlands). The Sf21 cells were maintained
at 25 ◦C on 1X Grace’s medium (Gibco® Life technologiesTM, Carslbad, CA, USA) supplemented with
10% heat-inactivated fetal bovine serum (FBS) in 25 cm2 cell culture flasks. Cells were passaged weekly.
Cell concentrations were measured by using an automatic cell counter (Countess Automated Cell
Counter from Invitrogen, Carlsbad, CA, USA).
4.4. Insect Bioassays
The bioassays for the three insect species were performed with first instar larvae. Five
different protoxin concentrations, ranging from 0.39 to 100 µg/mL, were prepared to determine
the concentration-mortality responses in order to calculate the mean lethal concentration (LC50). For
the lepidopteran insect species, O. nubilalis and L. botrana, the diet surface contamination assay was
used [61], and for L. decemlineata, the leaf dip bioassay described by Iriarte et al. [62], was performed.
For each bioassay, several protein concentrations were tested, using 28 larvae per concentration.
Each bioassay was repeated at least three times. Total insect mortality was recorded after 7 days for
lepidopteran insects, and after 4 days for L. decemlineata. The concentration-mortality data obtained
for each insect species were analyzed after transformation of the concentration-response curve to fit a
linear model using POLO-PC program (LeOra Software, Berkeley, CA, USA, 1987), based on the Probit
analysis [63].
4.5. Midgut Isolation and BBMV Preparation
Midguts were dissected from fifth-instar larvae of O. nubilalis and forth-instar larvae of L.
decemlineata. The dissected midguts were rinsed in ice-cold MET buffer (0.3 M mannitol, 5 mM EGTA,
17 mM Trsi-HCl, pH 7.5), snap frozen in liquid nitrogen and kept at −80 ◦C until use.
Brush border membrane vesicles (BBMV) were obtained from the dissected midguts of O. nubilalis
and L. decemlineata and from the whole last instar larvae of L. botrana, following the differential
magnesium precipitation method [64,65]. Proteins in the purified BBMV were quantified following
Bradford protein assay [59] and stored at −80 ◦C.
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4.6. Biotin Labelling
Trypsin activated Cry1Ia protein was biotinylated by using the protein biotinylation kit from GE
Healthcare (GE Healthcare, Little Chalfont, UK), as described elsewhere [66]. The eluted fractions
were quantified by NanoDrop 2000 spectrophotometer (ThermoFisher Scientific, Waltham, MA, USA),
analyzed by 12% SDS-PAGE and verified by Western blot. The protein fractions were concentrated by
using an Amicon Ultra-4 10K centrifugal filter device (Merck Millipore, Tullagreen, Ireland) and stored
at 4 ◦C.
The interference of biotin in oligomerization was tested following incubation of the biotin labelled
Cry1Ab with O. nubilalis BBMV. The detection of biotin labelled Cry1Ab oligomerization was performed
following the same protocol than has been described for Cry1Ia. The results showed no influence of
biotin in oligomerization (Figure S1), as had been already claimed by other authors that have used
biotin labelled proteins to detect oligomers [12,20,53,54].
4.7. Oligomerization Assays with Sf21 Cells
The confluent monolayer growing Sf21 cells were suspended in fresh Grace’s medium without FBS.
The cell concentration was measured (by using the Countess Automated Cell Counter from Invitrogen,
Carlsbad, California, USA), and 100 µL of cell suspension at a concentration of 2 × 106 cells/mL
were seeded into 96-well plates. The oligomerization assays were performed as described by
Portugal et al. [38] with slight modifications. In short, cells were incubated at 25 ◦C for at least 30 min.
Later, 4 µg of activated toxins (biotinylated Cry1Ia or unlabeled Cry1Ab) were added to the cells (final
concentration of 0.03 µg protein/µL) except in controls, which received 50 mM carbonate buffer pH 10.5.
The plates were incubated for 3 h at 25 ◦C. After the incubation, the treated cells were collected and
pelleted by centrifugation at 16,200× g, 4 ◦C for 15 min. The supernatants containing unbound proteins
were kept for further analysis. The controls (proteins alone, without cells) were submitted to the same
experimental conditions as treatments. After centrifugation of the controls, as there was no pellet due
to the absence of cells, a dilution of supernatant (containing 200 ng of selected protein) was analyzed
in the gel. The Sf21 cells in the pellet were washed once with 200 µL of 50 mM carbonate buffer pH
10.5, and recovered by centrifugation (45 min, 18,800× g). The final pellet was resuspended in 10 µL of
buffer and heated at 50 ◦C for 3 min. The proteins present in the sample were separated by SDS-PAGE
10% and electrotransferred onto polyvinylidene difluoride (PVDF) Western Blotting membrane (Roche
Diagnostics GmbH, Mannheim, Germany). The membrane was incubated overnight in blocking
buffer (PBST; 0.1% Tween 20 in phosphate-buffered saline, supplemented with 5% skimmed milk)
with gentle shaking, and washed three times with PBST, before incubation with the corresponding
antibodies. Cry1Ab protein was detected with polyclonal rabbit anti-Bt Cry1Ab/1Ac (1:10,000; 60 min)
from Abraxis (Warminster, PA, USA) followed by secondary antibody (1:20,000; 60 min) coupled
with horseradish peroxidase (HRP) (Sigma-Aldrich, Saint Louis, MO, USA), whereas biotinylated
Cry1Ia protein was detected by streptavidin-conjugated horseradish peroxidase (1:2000; 60 min) (GE
Healthcare, Amersham, UK). Both Cry1Ab and Cry1Ia proteins were visualized by chemiluminescence
using ECLTM prime western blotting detection reagent (GE Healthcare, Little Chalfont, UK) using an
ImageQuant LAS400 image analyzer (GE Healthcare Bio-Sciences, Upsala, Sweden). The molecular
weight marker used was Precision Plus Protein™ Dual Color Standard (Bio-Rad, Carlsbad, CA, USA).
Each oligomerization assay was repeated at least three times.
4.8. Oligomerization Assays with BBMV
The BBMV were centrifuged for 10 min at 16,000× g and suspended in 50 mM carbonate buffer pH
10.5. The oligomerization protocol was set up after reviewing the procedures described in the literature
for Cry1 proteins [17,18,37–39,45,47,51,52,54]. Finally, the oligomerization assays with BBMV were
performed following Ocelotl et al. [51] who employed the milder SDS-PAGE denaturing conditions
(heating the samples 3 min at 50 ◦C), with some modifications. Briefly, 2 µg of biotin labelled activated
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Cry1Ia and activated Cry1Ab toxins were incubated for one hour with 5 µg of L. botrana or L. decemlineata
BBMV, or with 20 µg of O. nubilalis BBMV, at 37 ◦C, in a final volume of 50 µL. Activated proteins
incubated in the absence of BBMV and samples containing only BBMV were used as controls. Then,
phenylmethylsulfoyl fluoride (PMSF) was added (final concentration 1 mM) and BBMV were recovered
by centrifugation at 18,400× g for 45 min at 4 ◦C. The supernatant containing unbound protein was
recovered and stored. The controls (samples with proteins and without BBMV) went through the
same experimental conditions as treatments. After centrifugation of the controls, a dilution of the
supernatant (containing 200 ng of selected protein) was analyzed in the gel to avoid the observation of
the over saturated signal in the membrane. In the samples containing BBMV, the pellet was washed
once with 100 µL ice-cold buffer. The final BBMV pellets were resuspended in 10 µl of the buffer.
After incubating the samples for 3 min at 50 ◦C, the proteins were separated by 10% SDS-PAGE
and blotted onto PVDF Western Blot membranes (Roche Diagnostics GmbH, Mannheim, Germany).
After Western blot, Cry1Ab was detected with polyclonal rabbit anti-Bt Cry1Ab/1Ac, and Cry1Ia was
detected by streptavidin-conjugated horseradish peroxidase as has been described in the previous
section. The experiments were repeated, at least, three times.
Supplementary Materials: The following is available online at http://www.mdpi.com/2072-6651/12/2/133/s1,
Figure S1: Biotin labelled Cry1Ab oligomer formation promoted by O. nubilalis BBMV.
Author Contributions: B.E. and Y.B. contributed to the design of the study. A.K. and M.D.-A. performed the
experiments. A.K., Y.B., B.E., P.C. and M.D.-A. analyzed the data. A.K., Y.B. and M.D.-A. wrote the manuscript.
All authors have read and agreed to the published version of the manuscript.
Funding: This work was supported by grants from the Spanish Ministry of Science, Innovation and Universities,
the State Research Agency of Spain and the European FEDER founds (Refs. AGL2015-70584-C2 and
RTI2018-095204-B-C21), and by the Generalitat Valenciana (GVPROMETEOII-2015-001). M. Domínguez received
a predoctoral fellowship from the Universidad Pública de Navarra, Spain.
Acknowledgments: We are deeply grateful to Patricia Hernández-Martínez for her valuable comments. We thank
Rosa Maria González-Martínez and Óscar Marin Vázquez for their support in laboratory assistance.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Van Frankenhuyzen, K. Insecticidal activity of Bacillus thuringiensis crystal proteins. J. Invertebr. Pathol. 2009,
101, 1–16. [CrossRef]
2. Ohba, M.; Mizuki, E.; Uemori, A. Parasporin, a new anticancer protein group from Bacillus thuringiensis.
Anticancer Res. 2009, 29, 427–433. [PubMed]
3. Palma, L.; Muñoz, D.; Berry, C.; Murillo, J.; Caballero, P. Bacillus thuringiensis toxins: An overview of their
biocidal activity. Toxins 2014, 6, 3296–3325. [CrossRef] [PubMed]
4. Chakroun, M.; Banyuls, N.; Bel, Y.; Escriche, B.; Ferré, J. Bacterial vegetative insecticidal proteins (Vip) from
entomophatogenic bacteria. Microbiol. Mol. Biol. Rev. 2016, 80, 329–350. [CrossRef] [PubMed]
5. Kostichka, K.; Warren, G.W.; Mullins, M.; Mullins, A.D.; Craig, J.A.; Koziel, M.G.; Estruch, A.D. Cloning of a
cryV-type insecticidal protein gene from Bacillus thuringiensis: The cryV-encoded protein is expressed early
in stationary phase. J. Bacteriol. 1996, 178, 2141–2144. [CrossRef]
6. Jurat-Fuentes, J.L.; Jackson, T.A. Bacterial entomopathoges. In Insect Pathology, 2nd ed.; Vega, F.E., Kaya, H.K.,
Eds.; Academic Press: San Diego, CA, USA, 2012; pp. 265–349. [CrossRef]
7. Hoffman, C.; Vanderbruggen, H.; Höfte, H.; Van Rie, G.; Jansens, S.; Van Mellaert, H. Specificity of Bacillus
thuringiensis delta-endotoxins is correlated with the presence of high-affinity binding sites in the brush border
membrane of target insect midguts. Proc. Natl. Acad. Sci. USA 1988, 85, 7844–7848. [CrossRef]
8. Ferre, J.; VanRie, J. Biochemistry and genetics of insect resistance to Bacillus thuringiensis. Annu. Rev. Entomol.
2002, 47, 501–533. [CrossRef]
9. Zhang, X.; Candas, M.; Griko, N.B.; Taussig, R.; Bulla, L.A., Jr. A mechanism of cell death involving an
adenylyl cyclase/PKA signaling pathway is induced by the Cry1Ab toxin of Bacillus thuringiensis. Proc. Natl.
Acad. Sci. USA 2006, 103, 9897–9902. [CrossRef]
Toxins 2020, 12, 133 12 of 15
10. Adang, M.J.; Crickmore, N.; Jurat-Fuentes, J.L. Diversity of Bacillus thuringiensis crystal toxins and mechanism
of action. Adv. Insect Physiol. 2014, 47, 39–87. [CrossRef]
11. Arenas, I.; Bravo, A.; Soberón, M.; Gómez, I. Role of alkaline phosphatase from Manduca sexta in the
mechanism of action of Bacillus thuringiensis Cry1Ab toxin. J. Biol. Chem. 2010, 285, 12497–12503. [CrossRef]
12. Vachon, V.; Raynald, L.; Schwartz, J.L. Current models of the mode of action of Bacillus thuringiensis
insecticidal crystal proteins: A critical review. J. Invertebr. Pathol. 2012, 111, 1–12. [CrossRef] [PubMed]
13. Pardo-López, L.; Soberón, M.; Bravo, A. Bacillus thuringiensis insecticidal three-domain Cry toxins: Mode
of action, insect resistance and consequences for crop protection. FEMS Microbiol. Rev. 2013, 37, 3–22.
[CrossRef] [PubMed]
14. Gomez, I.; Sanchez, J.; Miranda, R.; Bravo, A.; Soberon, M. Cadherin-like receptor binding facilitates
proteolytic cleavage of helix alpha-1 in domain I and oligomer pre-pore formation of Bacillus thuringiensis
Cry1Ab toxin. FEBS Lett. 2002, 513, 242–246. [CrossRef]
15. Rausell, C.; García-Robles, I.; Sánchez, J.; Muñoz-Garay, C.; Martínez-Ramírez, A.C.; Real, M.D.; Bravo, A.
Role of toxin activation on binding and pore formation activity of the Bacillus thuringiensis Cry3 toxins in
membranes of Leptinotarsa decemlineata (Say). Biochim. Biophys. Acta 2004, 1660, 99–105. [CrossRef]
16. Muñoz-Garay, C.; Portugal, L.; Pardo-López, L.; Jiménez-Juárez, N.; Arenas, I.; Gómez, I.; Sánchez-López, R.;
Arroyo, R.; Holzenburg, A.; Savva, C.G.; et al. Characterization of the mechanism of action of the genetically
modified Cry1AbMod toxin that is active against Cry1Ab-resistant insects. Biochim. Biophys. Acta 2009, 1788,
2229–2237. [CrossRef]
17. Tigue, N.; Jacoby, J.; Ellar, D.J. The α-helix residue, Asn135, is involved in the oligomerization of Cry1Ac1
and Cry1Ab5 Bacillus thuringiensis toxins. Appl. Environ. Microbiol. 2001, 67, 5715–5720. [CrossRef]
18. Herrero, S.; González-Cabrera, J.; Ferré, J.; Bakker, P.L.; de Maagd, R.A. Mutations in the Bacillus thuringiensis
Cry1Ca toxin demonstrate the role of domains II and III in specificity towards Spodoptera exigua larvae.
Biochem. J. 2004, 384, 507–513. [CrossRef]
19. Pérez, C.; Muñoz-Garay, C.; Portugal, L.; Sánchez, J.; Gill, S.S.; Soberón, M.; Bravo, A. Bacillus thuringiensis spp.
israelensis Cyt1Aa enhances activity of Cry11Aa toxin by facilitating the formation of a pre-pore oligomeric
structure. Cell Microbiol. 2007, 9, 2931–2937. [CrossRef]
20. Fabrick, J.; Oppert, C.; Lorenzen, M.D.; Morris, K.; Oppert, B.; Jurat-Fuentes, J.L. A novel Tenebrio molitor
cadherin is a functional receptor for Bacillus thuringiensis Cry3Aa toxin. J. Biol. Chem. 2009, 284, 18401–18410.
[CrossRef]
21. Groulx, N.; McGuire, H.; Laprade, R.; Schwartz, J.L.; Blunck, R. Single molecule fluorescence study of the
Bacillus thuringiensis toxin Cry1Aa reveals tetramerization. J. Biol. Chem. 2011, 286, 42274–42282. [CrossRef]
22. Carmona, D.; Rodríguez-Almazán, C.; Muñoz-Garay, C.; Portugal, L.; Pérez, C.; de Maagd, R.A.; Bakker, P.;
Soberón, M.; Bravo, A. Dominant negative phenotype of Bacillus thuringiensis Cry1Ab, Cry11Aa and Cry4Ba
mutants suggest hetero-oligomer formation among different Cry toxins. PLoS ONE 2011, 6, e19952. [CrossRef]
[PubMed]
23. Khomkhum, N.; Leetachewa, S.; Angsuthanasombat, C.; Moonsom, S. Functional assembly of 260-kDa
oligomers required for mosquito-larvicidal activity of the Bacillus thuringiensis Cry4Ba toxin. Peptides 2015,
68, 183–189. [CrossRef] [PubMed]
24. Xu, L.; Pan, Z.; Zhang, J.; Niu, L.; Li, J.; Chen, Z.; Liu, B.; Zhu, Y.; Chen, Q. Exposures of helices α4 and
α5 is required for insecticidal activity of Cry2Ab by prompting assembly of prepore oligomeric structure.
Cell. Microbiol. 2018, e12827. [CrossRef] [PubMed]
25. Abe, Y.; Inoue, H.; Ashida, H.; Maeda, Y.; Kinoshita, T.; Kitada, S. Glycan region of GPI anchored-protein
is required for cytocidal oligomerization of an anticancer parasporin-2, Cry46Aa1 protein, from Bacillus
thuringiensis strain A1547. J. Invertebr. Pathol. 2017, 142, 71–81. [CrossRef]
26. López-Diaz, J.; Cantón, P.E.; Gill, S.S.; Soberón, M.; Bravo, A. Oligomerization is a key step in Cyt1Aa
membrane insertion and toxicity but not necessary to synergize Cry11Aa toxicity in Aedes aegypti larvae.
Environ. Microbiol. 2013, 15, 3030–3039. [CrossRef]
27. Palma, L.; Scott, D.J.; Harris, G.; Din, S.; Williams, T.L.; Reoberts, O.J.; Young, M.T.; Caballero, P.; Berry, C.
The Vip3Ag4 insecticidal protoxins from Bacillus thuringiensis adopts a tetrameric configuration that is
maintained on proteolysis. Toxins 2017, 9, 165. [CrossRef] [PubMed]
28. Guo, S.; Zhang, Y.; Song, F.; Zhang, J.; Huang, D. Protease-resistant core form of Bacillus thuringiensis Cry1Ie:
Monomeric and oligomeric forms in solution. Biotechnol. Lett. 2009, 31, 1769–1774. [CrossRef]
Toxins 2020, 12, 133 13 of 15
29. Tailor, R.; Tippett, J.; Gibb, G.; Pells, S.; Pike, D.; Jordan, L.; Ely, S. Identification and characterization of a novel
Bacillus thuringiensis delta-endotoxin entomocidal to coleopteran and lepidopteran larvae. Mol. Microbiol.
1992, 6, 1211–1217. [CrossRef]
30. Choi, S.K.; Shin, B.S.; Kong, E.M.; Rho, H.M.; Park, S.H. Cloning of a new Bacillus thuringiensis cry1I-type
crystal protein gene. Curr. Microbiol. 2000, 41, 65–69. [CrossRef]
31. Xu, L.; Ferry, N.; Wang, Z.; Zhang, J.; Edwards, M.G.; Gatehouse, A.M.R.; He, K. A proteomic approach to
study the mechanism of tolerance to Bt toxins in Ostrinia furnacalis larvae selected for resistance to Cry1Ab.
Transgenic Res. 2013, 22, 1155–1166. [CrossRef]
32. Zhang, T.; He, M.; Gatehouse, A.M.R.; Wang, Z.; Edwards, M.G.; Li, Q.; He, K. Inheritance patterns,
dominance and cross-resistance of Cry1Ab- and Cry1Ac-selected Ostrinia furnacalis (Guenée). Toxins 2014, 6,
2694–2707. [CrossRef] [PubMed]
33. Xu, L.; Wang, Z.; Zhang, J.; He, K.; Ferry, N.; Gatehouse, A.M.R. Cross-resistance of Cry1Ab-selected Asian
corn borer to other Cry toxins. J. Appl. Entomol. 2010, 134, 429–438. [CrossRef]
34. Guo, J.; He, K.; Hellmich, R.L.; Bai, S.; Zhang, T.; Liu, Y.; Ahmed, T.; Wang, Z. Field trials to evaluate the
effects of transgenic cry1Ie maize on the community characteristics of arthropod natural enemies. Sci. Rep.
2016, 6, 22102. [CrossRef] [PubMed]
35. Fan, C.; Wu, F.; Dong, J.; Wang, B.; Yin, J.; Song, X. No impact of transgenic cry1Ie maize on the diversity,
abundance and composition of soil fauna in a 2-year field trial. Sci. Rep. 2019, 9, 10333. [CrossRef]
36. Rausell, C.; Muñoz-Garay, C.; Miranda-CasoLuengo, R.; Gómez, I.; Rudiño-Piñera, E.; Soberón, M.; Bravo, A.
Tryptophan spectroscopy studies and black lipid bilayer analysis indicate that the oligomeric structure
of Cry1Ab toxin from Bacillus thuringiensis is the membrane-insertion intermediate. Biochem. J. 2004, 43,
166–174. [CrossRef]
37. Gómez, I.; Sánchez, J.; Muñoz-Garay, C.; Matus, V.; Gill, S.S.; Soberón, M.; Bravo, A. Bacillus thuringiensis
Cry1A toxins are versatile proteins with multiple modes of action: Two distinct pre-pores are involved in
toxicity. Biochem. J. 2014, 459, 383–396. [CrossRef]
38. Portugal, L.; Gringorten, J.L.; Caputo, G.F.; Soberón, M.; Muñoz-Garay, C.; Bravo, A. Toxicity and mode of
action of insecticidal Cry1A proteins from Bacillus thuringiensis in an insect cell line, CF-1. Peptides 2014, 53,
292–299. [CrossRef]
39. Nair, M.S.; Dean, D.H. Composition of the putative prepore complex of Bacillus thuringiensis Cry1Ab toxin.
Adv. Biol. Chem. 2015, 5, 179–188. [CrossRef]
40. Khorramnejad, A.; Bel, Y.; Hernández-Martínez, P.; Talaei-Hassanloui, R.; Escriche, B. Insecticidal activity
and cytotoxicity of Bacillus thuringiensis Cry1Ia7 protein. In GMOs in Integrated Plant Protection; Meissle, M.,
De Schrijver, A., Smagghe, G., Eds.; IOBC-WPRS Bulletin: Ghent, Belgium, 2018; Volume 131, pp. 56–63.
41. Martínez-Solis, M.; Pinos, D.; Endo, H.; Portugal, L.; Sato, R.; Ferré, F.; Herrero, S.; Hernández-Martínez, P.
Role of Bacillus thuringiensis Cry1A toxins domains in the binding to the ABCC2 receptor from Spodoptera
exigua. Insect. Biochem. Mol. Biol. 2018, 101, 47–56. [CrossRef]
42. Crickmore, N.; Zeigler, D.R.; Feitelson, J.; Schnepf, E.; Van Rie, J.; Lereclus, D.; Baum, J.; Dean, D.H. Revision
of the nomenclature for the Bacillus thuringiensis pesticidal crystal proteins. Microbiol. Mol. Biol. Rev. 1998,
62, 807–813. [CrossRef]
43. Masson, L.; Erlandson, M.; Puzstai-Carey, M.; Brousseau, R.; Juárez-Pérez, V.; Frutos, R. A holistic approach
for determining the entomopathogenic potential of Bacillus thuringiensis strains. Appl. Environ. Microbiol.
1998, 46, 4782–4788. [CrossRef]
44. Ruiz de Escudero, I.; Estela, A.; Porcar, M.; Martínez, C.; Oguiza, J.A.; Escriche, B.; Ferré, J.; Caballero, P.
Molecular and insecticidal characterization of a Cry1I protein toxic to insects of the families Noctuidae,
Tortricidae, Plutellidae and Chrysomelidae. Appl. Environ. Microbiol. 2006, 72, 4796–4804. [CrossRef]
[PubMed]
45. Jiménez-Juárez, N.; Muñoz-Garay, C.; Gómez, I.; Saab-Rincon, G.; Damian-Almazo, J.Y.; Gill, S.S.; Soberón, M.;
Bravo, A. Bacillus thuringiensis Cry1Ab mutants affecting oligomer formation are not-toxic to Manduca sexta
larvae. J. Biol. Chem. 2007, 282, 21222–21229. [CrossRef]
46. Likitvivatanavong, S.; Katzenmeier, G.; Andsuthanasombat, C. Asn183 in α5 is essential for oligomerization
and toxicity of the Bacillus thuringiensis Cry4Ba toxin. Arch. Biochem. Biophys. 2005, 445, 46–55. [CrossRef]
Toxins 2020, 12, 133 14 of 15
47. Rodríguez-Almazán, C.; Zavala, L.E.; Muñoz-Garay, C.; Jiménez-Juárez, N.; Pacheco, S.; Masson, L.;
Soberón, M.; Bravo, A. Dominant negative mutants of Bacillus thuringiensis Cry1Ab toxin function as
anti-toxins: Demonstration of the role of oligomerization in toxicity. PLoS ONE 2009, 4, e5545. [CrossRef]
[PubMed]
48. Jurat Fuentes, J.L.; Adang, M.J. Cry toxin mode of action in susceptible and resistant Heliothis virescens larvae.
J. Invertebr. Pathol. 2006, 92, 166–171. [CrossRef]
49. Sekar, V.; Held, B.; Tippet, J.; Amirhusin, B.; Robeff, P.; Wang, K.; Wilson, H.M. Biochemical and Molecular
Characterization of the insecticidal fragment of CryV. Appl. Environ. Microbiol. 1997, 63, 2798–2801.
[CrossRef]
50. Crava, C.M.; Bel, Y.; Escriche, B. Bacillus thuringiensis susceptibility variation among Ostrinia nubilalis
populations. In Future Research and Development in the Use of Microbial Agents and Nematodes for Biological Insect
Control; Ehlers, R.U., Crickmore, N., Enkerli, J., Glazer, I., Lopez-Ferber, M., Tkaczuk, C., Eds.; IOBC-WPRS
Bulletin: Pamplona, Spain, 2009; Volume 45, pp. 171–174.
51. Ocelotl, J.; Sánchez, J.; Arroyo, R.; Gracía-Gómez, B.I.; Gómez, I.; Unnithan, G.C.; Tabashnik, B.E.; Bravo, A.;
Soberón, M. Binding and oligomerization of modified and native Bt toxins in resistance and susceptible pink
bollworm. PLoS ONE 2015, 10. [CrossRef]
52. Ocelotl, J.; Sánchez, J.; Gómez, I.; Tabashnik, B.E.; Bravo, A.; Soberón, M. ABCC2 is associated with Bacillus
thuringiensis Cry1Ac toxin oligomerization and membrane insertion in diamondback moth. Sci. Rep. 2017, 7,
2386. [CrossRef]
53. Padilla, C.; Pardo-López, L.; de la Riva, G.; Gómez, I.; Sánchez, J.; Hernandez, G.; Nuñez, M.E.; Carey, M.P.;
Dean, D.H.; Alzate, O.; et al. Role of tryptophan residues in toxicity of Cry1Ab toxin from Bacillus thuringiensis.
Appl. Environ. Microbiol. 2006, 72, 901–907. [CrossRef]
54. Chakroun, M.; Sellami, S.; Ferré, J.; Tounsi, S.; Rouis, S. Ephestia kuehniella tolerance to Bacillus thuringiensis
Cry1Aa associated with reduced oligomer formation. Biochem. Biophys. Res. Commun. 2017, 482, 808–813.
[CrossRef] [PubMed]
55. Rodríguez-Almazán, C.; Reyes, E.Z.; Zúñiga-Navarrete, F.; Muñoz-Garay, C.; Gómez, I.; Evans, A.M.;
Likitvivatanavong, S.; Bravo, A.; Gill, S.S.; Soberón, M. Cadherin binding is not a limiting step for Bacillus
thuringiensis subsp. israelensis Cry4Ba toxicity to Aedes aegypti larvae. Biochem. J. 2012, 443, 711–717.
[CrossRef] [PubMed]
56. Sayyed, A.H.; Gatsi, R.; Ibiza-Palacios, M.; Escriche, B.; Wright, D.J.; Crickmore, N. Common, but
complex, mode of resistance of Plutella xylostella to Bacillus thuringiensis toxins Cry1Ab and Cry1Ac.
Appl. Environ. Microbiol. 2005, 11, 6863–6868. [CrossRef] [PubMed]
57. Crava, C.M.; Bel, Y.; Jakubowska, A.K.; Ferré, J.; Escriche, B. Midgut aminopeptidase N isoforms from
Ostrinia nubilalis: Activity characterization and differential binding to Cty1Ab and Cry1Fa proteins from
Bacillus thuringiensis. Insect. Biochem. Mol. Biol. 2013, 43, 924–935. [CrossRef] [PubMed]
58. Stewart, G.S.; Johnstone, K.; Hagelberg, E.; Ellar, D.J. Commitment of bacterial spores to germinate. A measure
of the trigger reaction. Biochem. J. 1981, 196, 101–106. [CrossRef] [PubMed]
59. Bradford, M.M. A rapid and sensitive method for the quantification of microgram quantities of protein using
the principle of dye-binding. Anal. Biochem. 1976, 72, 248–254. [CrossRef]
60. MacIntosh, S.C.; Stone, T.B.; Sims, S.R.; Hunst, P.L.; Greenplate, J.T.; Marrone, P.G.; Perlak, F.J.; Fischhoff, D.A.;
Fuchs, R.L. Specificity and efficacy of purified Bacillus thuringiensis proteins against agronomically important
insects. J. Invertebr. Pathol. 1990, 56, 258–266. [CrossRef]
61. Beegle, C.C. Bioassay methods for quantification of Bacillus thuringiensis δ-endotoxin. In Analytical Chemistry
of Bacillus Thuringiensis, 1st ed.; Hickle, L.A., Fitch, W.L., Eds.; American Chemical Society: Washington, DC,
USA, 1990; pp. 14–21. [CrossRef]
62. Iriarte, J.; Bel, Y.; Ferrandis, M.D.; Andrew, R.; Murillo, J.; Ferré, J.; Caballero, P. Environmental distribution
and diversity of Bacillus thuringiensis in Spain. Syst. Appl. Microbiol. 1998, 21, 97–106. [CrossRef]
63. Finney, D.J. Probit Analysis, 3rd ed.; Cambridge University Press: Cambridge, UK, 1971. [CrossRef]
64. Wolfersberger, M.G.; Luethy, P.; Maurer, A.; Parenti, P.; Sacchi, F.V.; Giordana, B.; Hanozet, G.M. Preparation
and partial characterization of amino acid transporting brush border membrane vesicles from the larval
midgut of the cabbage butterfly (Pieris brassicae). Comp. Biochem. Physiol. A Physiol. 1987, 86, 301–308.
[CrossRef]
Toxins 2020, 12, 133 15 of 15
65. Escriche, B.; Silva, F.S.; Ferré, J. Testing suitability of brush border membrane vesicles prepared from
whole larvae from small insects for binding studies with Bacillus thuringiensis CrylA(b) crystal protein.
J. Invertebr. Pathol. 1995, 65, 318–320. [CrossRef]
66. Hernández-Martínez, P.; Vera-Velasco, N.M.; Martínez-Solís, M.; Ghislain, M.; Ferré, J.; Escriche, B. Shared
binding sites for the Bacillus thuringiensis proteins Cry3Bb, Cry3Ca, and Cry7Aa in the African sweet potato
pest Cylas puncticollis (Brentidae). Appl. Environ. Microbiol. 2014, 80, 7545–7550. [CrossRef] [PubMed]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
